Although further investigation for the efficacy of the treatment with KIF18A inhibitor at later times post‐infection in vivo is required, inhibition of KIF18A would be an efficient therapeutic strategy for the treatment of IAV infection. The gene discussed is KIF18A; the disease is infection.